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Changes in plasma lipids with psychosocial stress are related to
hypertension status and the norepinephrine stress response
Abstract
Hypertension is a known risk factor for cardiovascular disease. Hypertensive individuals show
exaggerated norepinephrine (NE) reactivity to stress. Norepinephrine is a known lipolytic factor. It is
unclear if, in hypertensive individuals, stress-induced increases in NE are linked with the elevations in
stress-induced circulating lipid levels. Such a mechanism could have implications for atherosclerotic
plaque formation. In a cross-sectional, quasi-experimentally controlled study, 22 hypertensive and 23
normotensive men (mean +/- SEM, 45 +/- 3 years) underwent an acute standardized psychosocial stress
task combining public speaking and mental arithmetic in front of an audience. We measured plasma NE
and the plasma lipid profile (total cholesterol [TC], low-density-lipoprotein cholesterol [LDL-C],
high-density-lipoprotein cholesterol, and triglycerides) immediately before and after stress and at 20 and
60 minutes of recovery. All lipid levels were corrected for stress hemoconcentration. Compared with
normotensives, hypertensives had greater TC (P = .030) and LDL-C (P = .037) stress responses.
Independent of each other, mean arterial pressure (MAP) upon screening and immediate increase in NE
predicted immediate stress change in TC (MAP: beta = .41, P = .003; NE: beta = .35, P = .010) and
LDL-C (MAP: beta = .32, P = .024; NE: beta = .38, P = .008). Mean arterial pressure alone predicted
triglycerides stress change (beta = .32, P = .043) independent of NE stress change, age, and BMI. The
MAP-by-NE interaction independently predicted immediate stress change of high-density-lipoprotein
cholesterol (beta = -.58, P < .001) and of LDL-C (beta = -.25, P < .08). We conclude that MAP and NE
stress reactivity may elicit proatherogenic changes of plasma lipids in response to acute psychosocial
stress, providing one mechanism by which stress might increase cardiovascular risk in hypertension.
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ABSTRACT 
Hypertension is a known risk factor for cardiovascular disease. Hypertensive 
individuals show exaggerated norepinephrine (NE) reactivity to stress. NE is a known 
lipolytic factor. It is unclear if, in hypertensive individuals, stress-induced increases in NE 
are linked with the elevations in stress-induced circulating lipid levels. Such a mechanism 
could have implications for atherosclerotic plaque formation. In a cross-sectional, 
quasiexperimentally controlled study, 22 hypertensive and 23 normotensive men 
(mean±SEM:45±3years) underwent an acute standardized psychosocial stress task combining 
public speaking and mental arithmetic in front of an audience. We measured plasma NE and 
the plasma lipid profile [total cholesterol (TC), low-density-lipoprotein (LDL)-C, high-
density-lipoprotein (HDL)-C, and triglycerides (TG)] immediately before and after stress and 
at 20 and 60 min of recovery. All lipid levels were corrected for stress-hemoconcentration. 
Compared to normotensives, hypertensives had greater TC (p=.030) and LDL-C (p=.037) 
stress responses. Independent of each other, mean arterial pressure (MAP) upon screening 
and immediate increase in NE predicted immediate stress change in TC (MAP: β=.41, 
p=0.003, NE: β=.35, p=0.010) and LDL-C (MAP: β=.32, p=.024, NE: β=.38, p=0.008). MAP 
alone predicted TG stress change (β=.32, p=0.043), independent of NE stress change, age, 
and BMI. The MAP-by-NE interaction independently predicted immediate stress change of 
HDL-C (β=-.58, p<.001) and of LDL-C (β=-.25, p<.08). We conclude that MAP and NE 
stress reactivity may elicit proatherogenic changes of plasma lipids in response to acute 
psychosocial stress providing one mechanism by which stress might increase cardiovascular 
risk in hypertension. 
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INTRODUCTION 
Systemic hypertension ranks among the leading risk factors for adverse cardiovascular 
outcomes [1]; however, the mechanisms that link hypertension with increased incidence of 
cardiovascular events are not fully understood.  Sympathetic predominance is both a risk 
factor for developing sustained hypertension [2] and for developing cardiovascular disease 
(CVD) in those with sustained hypertension [3,4]. Markers of sympathetic activity such as 
norepinephrine (NE) levels are generally higher in hypertensives than normotensives, both at 
baseline and when confronted with a psychosocial stressor [5-9]. Furthermore, hypertensives 
tend to have greater total cholesterol (TC), triglycerides (TG), and low density lipoprotein 
cholesterol (LDL-C) levels, and lower levels of high-density lipoprotein cholesterol (HDL-C) 
[10]. The prevalence of hyperlipidaemia in hypertension is as high as 40% [11]. It is 
suggested that acute lipid stress responsivity may reflect processes that contribute to the 
development of raised blood cholesterol levels. Greater acute stress lipid responses predicted 
higher LDL-C, HDL-C, and TC:HDL-C ratios several years later [12]. However, little is 
known about interactions between sympathetic activity and plasma lipid levels during stress-
responses in hypertensive patients. 
Like NE, a raise in TC and its fractions can be elicited in response to acute 
psychosocial stressors in a laboratory setting [13,14]. One explanation for stress-related 
changes in blood lipids is through multifactorially caused changes in hemoconcentration 
[15], whereby acute loss of plasma volume within the intravascular space concentrates 
nondiffusable blood constituents and, thereby, increases blood lipid concentration [16,17]. 
However, findings are inconsistent with some studies suggesting elevations in blood lipids 
even after adjustment for changes in hemoconcentration [18,19]. 
A second explanation for stress-related changes in lipid concentrations is the 
metabolic effect of catecholamine spillover in response to acute psychosocial stress. Increases 
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in circulating NE induces lipolysis and releases free fatty acids (FFA) into the circulation [20] 
which, in turn, serves as a substrate for the resynthesis of TG and hepatic production of very 
low-density lipoprotein (VLDL)-C [21]. Increases in NE are associated with elevated plasma 
levels of TC, LDL-C, and HDL-C [22]. Furthermore, blood levels of TC, LDL-C, and TG are 
lower and HDL-C level are higher with α-adrenergic than with β-adrenergic blockade in 
patients with systemic hypertension [23-25]. However, effects of an acute psychosocial 
stressor shown to elicit large increases in NE on blood lipid levels, have not been compared 
between hypertensive and normotensive individuals, particularly not while controlling for 
hemoconcentration. Research linking NE to blood lipid increases in response to stress may be 
important for developing target interventions to reduce CVD risk in hypertension. 
The purpose of this study was threefold: First, we investigated blood lipid changes to 
the widely used Trier Social Stress Test (TSST), which combines a public speaking task and 
a mental arithmetic task performed in front of an audience [26] in a sample of otherwise 
healthy and unmedicated hypertensive and normotensive men. We hypothesized that 
hypertensives exhibit exaggerated changes in blood lipids to acute stress. Second, to 
investigate underlying mechanisms of such differences, we tested whether blood lipid levels 
are associated with NE levels and mean arterial blood pressure (MAP), both at baseline and 
in response to stress.  Since the TSST is known to evoke large increases in plasma NE 
[27,28], we hypothesized that NE levels would directly relate to stress-induced changes in 
plasma lipids corrected for hemoconcentration. Third, we tested whether interactions between 
MAP and NE stress change affected stress-induced changes in lipids.  
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METHODS 
Study population 
The study was part of a project assessing stress reactivity in systemic hypertension [9] 
and was formally approved by the Ethics Committee of the State of Zurich, Switzerland. We 
analyzed plasma lipids from 45 subjects representing the final sample for this part of the 
study. All participants provided written informed consent. With the aid of the Swiss Red 
Cross of Zurich and through advertisements, we recruited non-smoking hypertensive and 
normotensive men who, apart from hypertension, were otherwise in excellent physical and 
mental health, as confirmed by an extensive health questionnaire and telephone interview. 
Specific exclusion criteria, obtained by subjects’ self-report, were: regular heavy exercise, 
alcohol and illicit drug abuse; any heart disease, varicosis or thrombotic diseases, elevated 
blood sugar and diabetes, elevated cholesterol, liver and renal diseases, chronic obstructive 
pulmonary disease, allergies and atopic diathesis, rheumatic diseases, and current infectious 
diseases. In addition, participants were included only if they reported taking no medication, 
either regularly or occasionally. If the personal or medication history was not conclusive, the 
subjects’ primary care physician was contacted for clarification.  
 
Assessment of hypertension 
After a 15-min rest, three seated screening BP measurements were obtained on 
three separate days by a fully automated sphygmomanometry device (Omron 773, Omron 
Healthcare Europe B.V. Hoofddorp, The Netherlands), and the average BP was computed. 
Subjects were categorized into hypertensive and normotensive individuals following the 
WHO/ISH definition (systolic BP ≥ 140mmHg and/or diastolic BP ≥ 90mmHg) [29]. For 
the purpose of data reduction, the average mean arterial pressure (MAP) was calculated 
across all individuals according to the formula (2/3 diastolic BP + 1/3 systolic BP) and 
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used in analyses. The screening procedure yielded 22 hypertensive and 23 age-matched 
normotensive men (mean ± SEM age, 45.0 ± 2 years, range 22-65 years) with a complete 
plasma lipid profile.  
 
Psychosocial stress procedure 
All experimental sessions commenced between 2:00 pm and 4:00 pm and lasted for 
approximately 2 hours. Participants abstained from food and drinks (other than water) for 2 
hours before the experiment, and from physical exercise, alcohol and caffeinated beverages 
from the evening before the test day. To inflict acute psychosocial stress, we used the 
standardized and well-established Trier Social Stress Test (TSST), which elicits social 
evaluative threat and unpredictability of the stressor [26,30]. The task comprises 5 min of 
preparation, a mock job interview (5 minutes), and a mental arithmetic task (serial 
subtraction, 5 minutes) in front of an unknown panel of one man and one woman [26]. The 
TSST enables a naturalistic exposure to a psychosocially stressful situation and has 
repeatedly been found to induce profound endocrine and cardiovascular responses [26,30]. 
During the 45 min before introduction to the TSST and another 60 min after task completion, 
subjects remained seated in a quiet room.  
Via an indwelling catheter, blood samples were obtained under resting conditions 
(i.e. baseline levels) one minute before subjects were introduced to the TSST and 
immediately after completion of the TSST. Additional blood samples were drawn 20 and 
60 minutes after completion of the TSST. At the end of blood sampling, participants were 
debriefed and participation was financially remunerated with 80 Swiss Francs.  
 
Biochemical measures 
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For NE assessment, venous blood was drawn into EDTA-coated monovettes 
(ethylenediaminetetraacetic acid; Sarstedt, Numbrecht, Germany), and immediately 
centrifuged for 10 min at 2,000g; obtained plasma was stored at –80°C until analysis. 
Plasma NE was determined by high-pressure liquid chromatography (HPLC; detection 
limit: 0.25pg/ml; inter- and intra-assay coefficients of variation < 5%; Laboratory for Stress 
Monitoring, Göttingen, Germany). All samples from one subject were analyzed in the same 
run. 
Blood lipids [TC, HDL-C, and TG] were measured by standard laboratory 
procedures in plasma (Synlab, Augsburg, Germany) using a calorimetric system (AU, 
Olympus) and are expressed in mg/dl. LDL-C was calculated using the Friedewald 
formula: LDL-C = TC − HDL-C − (TG / 2.19). Hemoglobin  (Hb; g/dl) and hematocrit 
(Hc; %) were obtained by processing whole blood collected in 2.7ml EDTA tubes 
(Sarstedt, Rommelsdorf, Germany) on an automated hematology system (Advia 120, Bayer 
Diagnostics).  
 
Hemodynamic measures 
Heart rate data were obtained continuously via a portable heart rate monitor (Polar 
system, S810, Polar, Finland) [31]. Following previous methods, BP was measured 
continuously from 5 minutes before the introduction to the TSST to 5 minutes after 
completion of the TSST (i.e. average of speech and arithmetic BP) by the Vasotrac 
APM205A device (Medwave Inc., St. Paul, MN, USA) [9].  
 
Statistical analyses 
All calculations were performed using SPSS Inc. (11.0.1) software packages (SPSS, 
Chicago, IL). Data are presented as mean ± SEM. All tests were two-tailed with the level of 
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significance set at p<.05 and the level of borderline significance set at p≤10. In the case of 
missing data, cases were excluded listwise. Data were normally distributed and 
homogeneity of variance was given as indicated by Kolmogorov–Smirnov and Levene's 
tests, respectively. These tests were performed before statistical procedures were applied.  
We corrected all plasma lipid levels for stress-hemoconcentration following 
previous methods by computing stress-induced changes in plasma volume (i.e. stress-
hemoconcentration) from hemoglobin and hematocrit measures according to the formula 
by Dill and Costill [32,33].  
Univariate analyses of variance (ANOVAs) were calculated to test for differences in 
hypertensive versus normotensive subjects in terms of demographic characteristics and 
baseline levels of NE and plasma lipids (Table 1).  
To test whether hypertensives exhibit exaggerated changes of blood lipids to acute 
stress as compared to normotensives we calculated repeated measures ANOVAs with 2 
groups (hypertensive, normotensive) as an independent variable and the four periods in 
which lipids were measured (baseline, 1 min, 20 min, and 60 min post stress) as repeated 
dependent variables. Repeated measures ANOVAs were also calculated for group 
differences in repeated NE, BP, hematocrit, and hemoglobin levels. We applied the Huynh-
Feldt correction for the degrees of freedom. 
To investigate underlying mechanisms of elevated blood pressure effects on blood 
lipids, we used MAP as a continuous variable instead of categorizing hypertensive and 
normotensives into a dichotomous variable. The use of a continuous variable increases the 
effect size and the statistical power in regression analyses [34]. This is particularly 
desirable in the present analyses since we are including several control variables, which can 
affect statistical power in a sample of this size. To test whether blood lipid levels at 
baseline are associated with NE levels at baseline and MAP, we calculated hierarchical 
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linear regression equations entering all independent variables in one block. As the 
dependent variable, we entered baseline levels of lipid measures. As independent 
continuous variables we entered MAP and NE baseline levels. To test whether stress-
induced blood lipid changes are associated with stress changes in NE and MAP, we again 
calculated hierarchical linear regression equations regressing MAP and stress change in NE 
in one block on lipid stress changes due to stress (lipid level immediately after stress minus 
baseline level). As independent variables we entered MAP and the stress change of NE. To 
test whether an interaction between MAP and NE stress change affected stress changes in 
lipids, we additionally included interaction terms into the previous regression equations. 
Interaction terms were formed by multiplying MAP with the NE stress change score. 
We controlled for age and BMI in all regression analyses. However, to prevent 
model overfitting, none of the regression models considered more than five independent 
variables [35]. The optimal total sample size of n=42 to detect an expected effect size of 
0.35 in regression analyses with a power between 0.80 (maximum of 5 predictors) and 0.95 
(minimum of 1 predictor) was calculated a priori with the statistical software G-Power 
[36]. All regression parameters were Z-transformed prior to regression analyses to allow 
computation of interaction terms. Change scores for plasma lipids were computed on 
original data and transformed subsequently. We did not perform statistical adjustment for 
multiple tests because in the case of our specific pre-established hypotheses statistical 
adjustment might deem truly and clinically important associations insignificant [37].  
 
RESULTS 
Subjects’ characteristics 
Table 1 provides the characteristics of the 45 subjects studied according to their 
hypertension status. As expected, hypertensive subjects had higher systolic and diastolic BP 
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than normotensive subjects. In addition, hypertensives had higher BMI, and also higher 
plasma levels of NE at rest (i.e. immediately before stress) than normotensives. 
 
Hypertension status and stress changes of lipids and other physiological parameters 
The TSST caused significant increases in NE, HR, BP, hematocrit, and hemoglobin 
(Figure 1) as well as in TG (all p’s <0.05), with a trend towards statistical significance seen 
for TC (p<0.07) (Figure 2). In addition, HDL-C showed an immediate decrease to stress 
exposure in all subjects (p<0.05) 
Lipids: Between rest and 60 min post-stress (Figure 2), repeated measures ANOVA 
revealed a greater response to stress in TC (interaction group-by-stress: F(2.5/107.8)=3.31, 
p=0.030) and LDL-C (interaction group-by-stress: F(3.0/127.6)=2.92, p=0.037) in 
hypertensives than normotensives. In contrast, there was no difference in the stress response 
for HDL-C (p=.52) and TG (p=.13) levels between the two groups. 
NE, HR, BP, hematocrit, and hemoglobin: Figure 1 shows that hypertensives had 
higher NE levels, both at baseline and after psychosocial stress relative to normotensives 
(group effect: F(1/43)=4.83, p=0.033). As expected, SBP and DBP were higher in 
hypertensives than in normotensives (p’s<.001). In contrast, hypertensives did not 
significantly differ from normotensives before and after stress in terms of HR, hematocrit and 
hemoglobin (p’s >.26).  
 
Associations between lipid levels and NE 
At rest: NE baseline level significantly predicted TC (β=.32, p=.030; ∆R2=.105). This 
effect lost significance (p=.22) after controlling for age (p=.09), BMI (p=.93), and MAP 
(p=.66). Similarly, NE baseline level significantly predicted LDL-C (β=.32, p=.032; 
∆R2=.102). This effect became nonsignificant (p=.22) after controlling for age (p=.20), BMI 
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(p=.85), and MAP (p=.76). There were no associations between NE baseline levels and TG 
(p=.77) and HDL-C (p=.23). 
Stress changes from baseline to immediately post-stress:  MAP and stress change in 
NE predicted TC and LDL-C stress changes independently of each other; MAP and NE stress 
change together explained 28% of the total variance in stress change of TC (MAP: β=.41, 
p=.003, ∆R2=.166; NE: β=.35, p=.010, ∆R2=.125) and 23% of the total variance in stress 
change of LDL-C (MAP: β=.32, p=.024, ∆R2=.101; NE: β=.38, p=.008, ∆R2=.143). 
Additional controlling for age and BMI did not significantly change results of TC but of 
LDL-C (Table 2). MAP significantly predicted TG stress change (MAP: β=.32, p=.040, 
∆R2=.092) after controlling for age (p=.11) and BMI (p=.10). Additional controlling for NE 
stress change (p=.68) did not significantly affect this relationship. Neither MAP nor NE stress 
change significantly predicted HDL-C stress change. 
 
 Interactions of MAP with NE stress change and stress change in lipids 
The MAP-by-NE stress change interaction significantly predicted stress change in 
LDL-C (β=-.27, p=.045, ∆R2=.072) and in HDL-C (β=-.61, p<.001, ∆R2=.39) when 
controlling for MAP and NE stress change. Additional controlling for age and BMI 
marginally affected the relationship with stress change in LDL-C (β=-.25, p=.073) but not 
with stress change in HDL-C (β=-.58, p<.001). The interaction between MAP and NE stress 
change was not significantly associated with stress changes in TC and in TG.  
 
 
DISCUSSION 
We examined whether hypertensives exhibit exaggerated changes of blood lipids to 
acute stress and whether blood lipid levels are associated with NE plasma levels and MAP (as 
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continuous assessment of hypertension status), both at baseline and in immediate response to 
stress. Moreover, we tested whether interactions between MAP and NE stress change affected 
stress-induced changes in lipids. Our findings extend prior research on acute stress reactivity 
in hypertension and associated risk for CVD, elucidating potential mechanisms involving 
associations between MAP, sympathetic activity, and plasma lipid levels during acute stress-
responses in hypertensive patients. 
We found that hypertensives showed greater TC and LDL-C stress changes that were 
sustained up to 60 min post stress than normotensives. Screening MAP, independent of NE, 
BMI and age, was associated with immediate stress changes in TC, TG and LDL-C such that 
the higher the MAP, the greater the stress-induced changes in plasma levels of these 
proatherogenic blood lipids. Moreover, independent of age, BMI, and MAP, greater stress-
induced NE release was independently associated with increased immediate stress-associated 
changes in TC and LDL-C levels. These findings suggest that both, NE and MAP are 
important factors associated with the observed differences between hypertensives and 
normotensives in the lipid response to stress. In other words, our data suggest that there is a 
second path linking BP or hypertension status with short-term stress changes of pro-
atherogenic lipids that is not mediated via NE, as would be predicted [17,23,24]. In addition, 
greater baseline NE levels were associated with higher baseline TC and LDL-C levels in 
hypertensives and normotensives, although not independent of age and BMI. This is 
consistent with previous studies showing that blood lipid levels are partially regulated by 
steady state sympathetic activity [38].  
Our findings extend previous observations of acute lipolytic properties of NE [20] for 
the first time to hypertensive patients and suggest a potentially important clinical mechanism 
contributing to the association between stress and CVD [39-41], particularly in hypertension.  
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How could hypertension status and NE influence blood lipid changes? Lipolysis is thought to 
occur through catecholamine stimulation of adrenergic receptors expressed on the cell-
surface membrane of fat cells [20,42] Notably, some recent findings also suggest additional 
mechanisms for NE-induced lipolysis, not related to adrenoceptors [42]. Our data further 
suggest that during acute stress hypertension might be associated with hitherto unknown lipid 
metabolic processes that are unrelated to NE change and stress-hemoconcentration [17]. 
However, we feel it is premature to speculate on such mechanisms since stress-triggered NE 
release from sympathetic nerve endings and the adrenal medulla only partially reflect 
sympathetic nervous system activity during stress. For instance, we did not assess adrenergic 
receptor functioning and polymorphisms and their role in stress-induced lipid changes in 
relation to hypertension [43]. 
While it is known that elevated baseline levels of TC and LDL-C are associated with 
increased risk of atherogenesis [10], it is unknown whether acute changes in lipids, as 
observed in our study, are of clinical relevance. To what extent do acutely increased lipids 
deposit at sites of endothelial lesions, thereby contributing to the initiation of the fatty streak, 
atherosclerosis progression, and ultimately coronary occlusion [44]? Do such processes 
increase the CVD risk particularly in hypertension? It is suggested that the frequency of 
stress-induced bouts of NE release are of clinical importance [45] and the same may be true 
in terms of changes in lipid levels. Over a life span, an acutely exaggerated lipid response 
could contribute to clinically manifest atherosclerosis in hypertensives. Such reasoning is 
corroborated by prior research suggesting that among hypertensives, exaggerated 
behaviorally evoked cardiovascular reactivity is associated with greater carotid intima-media 
thickness, a subclinical marker of atherosclerosis [46]. 
The interaction between MAP and NE stress change was negatively associated with 
the immediate stress-associated change of HDL-C (β=-.64) and LDL-C (β=-.31). In other 
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words, the higher MAP and the NE stress response, the stronger the decrease of HDL-C and 
of LDL-C. A negative association may be anticipated with the potentially anti-atherogenic 
lipid, HDL-C, which corresponds with the idea that a decrease in “good lipids” in 
hypertensives during stress increases CVD risk [1,39]. However, MAP and NE stress change 
were also negatively associated with the potentially proatherogenic lipid, LDL-C, which 
seems counterintuitive; however, the association was not independent of age and BMI and 
should therefore not be overinterpreted. Thirty-nine % of the total variance in HDL-C was 
explained by the interaction of MAP with NE. This suggests a mechanism potentially 
mediating cardiovascular risk of hypertension in response to mental stress. Furthermore, 
HDL-C levels were reduced immediately after stress in all subjects, suggesting that acute 
stress effects on HDL-C may lead to potential atherosclerotic harm in healthy individuals, 
independent of NE.   
Our study possesses several strengths, including recruitment of apparently healthy and 
unmedicated subjects with reasonable health habits. This is important since blood lipid 
metabolism is affected by numerous drugs (incl. antihypertensives), and lifestyle factors [47].  
Potential confounding factors were reduced in the analyses by controlling for age and BMI. 
Additionally, plasma lipid levels were corrected for stress-induced shifts in 
hemoconcentration prior to all analyses. The study also has its limitations. The significant 
associations between MAP, NE levels, and their interactions in determining lipid levels are 
correlational and do not prove a causal link. For instance, some investigators suggest that 
having high normal BP and concomitant elevated serum cholesterol may lead to exaggerated 
cardiovascular responses to stress, due to endothelial dysfunction resulting from 
abnormalities of lipid metabolism [48]. Because of the sample size, conclusions pertaining to 
relationships observed between MAP and NE and specific lipids must be drawn with caution. 
In addition, our findings were obtained in a sample of apparently healthy men with BP in the 
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normotensive and mildly hypertensive range and may not be generalizable to individuals with 
more severe hypertension and women. Also, we did not include a non-stressed control group 
to validate whether changes in lipid levels were unequivocally caused by the TSST. 
However, since decrease in TC takes several hours during the morning [49] and LDL-C and 
HDL-C both remain relatively constant over 24h [50], it is likely that diurnal effects did not 
evidently affect the time course of changes in plasma lipids. 
In sum, we found evidence for our hypothesis that screening MAP and NE stress 
change are associated with acute stress changes of several blood lipids that are associated 
with cardiovascular disease. By eliciting a proatherogenic lipid profile, stress may accelerate 
the atherogenic process early-on in otherwise healthy hypertensive men or may even 
contribute to artery occlusion in coronary patients. Our observations require replication in 
larger samples and other populations, and the underlying mechanisms remain to be 
elucidated. 
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Table 1. Characteristics of the 45 subjects studied 
    
 Hypertensives (n=22) Normotensives (n=23) p-value 
    
Age [years] 46.3 ± 3.0 44.6 ± 2.4 0.659 
Body mass index [kg/m2] 27.1 ± .65 25.1 ± .49 0.016 
Systolic blood pressure [mmHg] 150 ± 1.9 121 ± 1.5 <0.001 
Diastolic blood pressure 
[mmHg] 
95 ± 1.8 78 ± 1.4 <0.001 
MAP [mmHg] 113.3 ± 1.7 92.4 ± 1.4 <0.001 
Cholesterol [mg/dl] 217.8 ± 8.9 210.4 ± 7.7 0.534 
Triglycerides [mg/dl] 218.6 ± 34.7 216.6 ± 25.5 0.962 
LDL-C [mg/dl] 134.6 ± 5.8 129.8 ± 5.6 0.554 
HDL-C [mg/dl] 49.5 ± 3.0 49.8 ± 2.8 0.938 
NE [pg/ml] 426.6 ± 24.7 327.8 ± 24.0 0.006 
 
Values are given as mean±SEM. MAP, mean arterial blood pressure, Plasma lipid and stress 
hormone measures reflect plasma levels at baseline (i.e. immediately before the stressor).  
 
 
 23 
 Table 2.  Hierarchical regression analyses for associations between stress changes  
in norepinephrine (NE) and lipids  
Variables entered  Standardized 
β-coefficient 
t P R2 change 
Cholesterol stress change  
Age 
Body Mass Index 
MAP 
NE stress change 
  
.08 
.15 
.35 
.35 
 
.53 
.80 
2.51 
2.48 
 
.43 
.43 
.016 
.017 
 
.00 
.01 
.11 
.11 
LDL-C stress change 
Age 
Body mass index 
MAP 
NE stress change 
  
.08 
.21 
.24 
.38 
 
.55 
1.38 
1.65 
2.70 
 
.59 
.18 
.11 
.01 
 
.01 
.03 
.05 
.13 
Triglyceride stress change 
Age 
Body mass index 
MAP 
 .26 
-.28 
.32 
1.65 
-1.72 
2.09 
.11 
.09 
.043 
.06 
.06 
.09 
NE stress change  -.06 -.37 .71 .00 
HDL-C stress change 
Age 
Body Mass Index 
MAP 
NE stress change 
  
-.04 
.34 
.02 
.10 
 
-.26 
2.06 
.14 
.62 
 
.80 
.046 
.89 
.54 
 
.00 
.09 
.00 
.01 
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Stress change, difference between immediate post-stress level and baseline; MAP, mean 
arterial blood pressure; NE, norepinephrine; LDL-C, low density cholesterol; HDL-C, high 
density cholesterol. 
 
 
 
 
 
                                               
 25 
FIGURE LEGENDS 
Legend to Figure 1 
Values are means±SEM. Across all subjects, the stressor elicited significant 
responses in NE, HR, BP, hematocrit, and hemoglobin (p’s<0.001). Hypertensive men 
showed relatively higher NE (p=0.033, Panel A) as well as higher systolic and diastolic BP 
levels (p’s<0.001) before and after stress (Panels C and D). Hypertensives and normotensives 
did not significantly differ in their hematocrit (Panel E) and hemoglobin (Panel F) levels 
before and after stress.  
 
Legend to Figure 2 (Panels A-B) 
Values are means±SEM. Stress elicited significant changes in triglycerides and HDL-
C (p’s <0.05), with a similar trend seen for total cholesterol (p<0.07) (Panels A – D). 
Hypertensives showed greater total cholesterol (Panel A) and LDL-C (Panel B) changes 
relative to normotensives (p`s<0.037). The groups were not significantly different in HDL-C 
(Panel C) and triglyceride (Panel D) stress responses. 
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Figure 1 A-F. Changes of norepinephrine, heart rate, blood pressure, hematocrit, and 
hemoglobin to psychosocial stress in hypertensive and normotensive men 
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Figure 2 A-D. Plasma lipid changes to psychosocial stress in hypertensive and 
normotensive men  
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